Gene evolution reversed

Time travel may be possible, at least in a laboratory -- researchers have reconstructed a now-extinct vertebrate gene that split into parts 500 million years ago. During the study, published this week in Developmental Cell, researchers replaced two mouse genes with a synthesized "ancestral" version that contains parts of both. "The most striking finding was that we succeeded in 'simplifying' the mouse genome," said Petr Tvrdik, lead author of the study. "We could replace two genes that are obviously essential by a single, bifunctional gene."Tvrdik and his coauthor Mario Capecchi, both at the University of Utah in Salt Lake City, focused on the mouse Hoxa1 and Hoxb1 genes, the two most significant descendants of the ancient vertebrate Hox1 gene. The Hox family of genes, all of which have between two and four paralogs in modern vertebrates, play an essential role in embryo development. The Hox1 paralogs help to shape the central hindbrain -- mice lacking Hoxb1 are deficient in motor neuron function and can't perform certain facial movements such as blinking. Mice lacking Hoxa1 have a defective breathing mechanism, and die soon after birth. In humans, Hoxa1 mutations sometimes occur; victims survive into adulthood, but suffer from impaired eye movements, deafness, delayed motor development, and breathing difficulties.Researchers had previously hypothesized that Hox paralogs encode similar proteins and differ mainly in their regulatory sequence. To test this in the case of Hoxa1 and Hoxb1, Tvrdik and Capecchi swapped the protein-coding regions of the two genes. The mice turned out to be normal. "We did find subtle differences, but the mice were happy with swapped genes," Tvrdik said. "Intrigued by this, we asked if we could go even further in constructing a single gene that would perhaps do both of these seemingly separated functions in the mouse brain." Hoxa1 and Hoxb1 switch on around the same time in a mouse embryo. But due to differences in the regulatory sequence, one remains active only for about a day, while the other continues to act for several more days. Since Hoxa1's protein can substitute for that of Hoxb1 in the brain, Tvrdik and Capecchi hypothesized that if Hoxa1's activation pattern could be suitably modified, it could take over Hoxb1's function as well -- essentially reverting to the ancient Hox1 gene. To achieve this synthesis, the researchers inserted Hoxb1's autoregulatory element, a 107 bp sequence, into Hoxa1's promoter. In mice with Hoxb1 knocked out, two copies of this composite gene restored viability and normal facial movements. "Rather strikingly, the mouse with the bifunctional Hoxa1 gene was fine even in the absence of the other gene," Tvrdik said.Based on their results, the researchers propose a new form of gene therapy, where a small regulatory fragment from a defective gene could be used to activate a similar, but functional, gene. This might require much less DNA transfer compared to conventional gene therapy since only a small regulatory fragment needs to be inserted into the second gene, Tvrdik said."Perhaps the most astonishing finding from this work is that mice can survive with normal neurological functions given one functional Hox1 paralog in place of the Hoxa1/Hoxb1 pair, Jonathan Eggenschwiler of the department of Molecular Biology at Princeton University said in an Email. However, Eggenschwiler, who was not involved in the paper, added that even though mice with a single version of Hox1 appear normal, "slight positive selective pressure in favor of two diversified Hox1 paralogs may only be evident over long evolutionary timescales."The study highlights the importance of the cis-regulatory elements in the divergence of gene function, said Steven Potter of the Developmental Biology department at the Cincinnati Children's Hospital Medical Center, also not a co-author. The elegant and novel feature of the study, according to Potter, is that the authors combine the cis-regulatory elements from different paralogs to create a multifunctional Hox gene. "That was a bold experiment," he said. "I probably would have never tried it, because I wouldn't have thought it could work."Chandra Shekhar cshekhar@the-scientist.comLinks within this articleP. Tvrdik and M. Capecchi, "Reversal Hox1 gene subfunctionalization in the mouse," Developmental Cell, 11:1-12, August 2006. http://www.developmentalcell.com/Petr Tvrdik http://capecchi.genetics.utah.edu/labmembers.htmlMario Capecchi http://capecchi.genetics.utah.edu/C. Holding, "Hox: Total knockout," The Scientist, July 18, 2003. http://www.the-scientist.com/article/display/21472/S. Blackman, "Old genes, new tricks," The Scientist, August 28, 2003. http://www.the-scientist.com/article/display/21554/J.M. Greer at al., "Maintenance of functional equivalence during paralogous Hox gene evolution," Nature, 403(6770):661-5, Feb 10, 2000. PM_ID: 10688203 Jonathan Eggenschwiler http://www.molbio.princeton.edu/research_facultymember.php?id=57Stephen Potter http://www.cincinnatichildrens.org/research/div/dev-biology/fs/fac/steven-potter.htm

Gene evolution reversed

The Scientist ARCHIVES

Become a Member of

Keywords

Meet the Author

Chandra Shekhar

Related Research Resources

Bunsen Burners and Bad Hair Days

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Meet Honeybun and Breeze Through Viscometry in Formulation Development

Taking the Guesswork Out of Quality Control Standards

PFAS: The Forever Chemicals

Unlocking the Unattainable in Gene Construction

Products

Product News

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Thermo Scientific™ Centrifuges with GreenCool Technology

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Launches Research Grant to Empower Mapping the RNome